Clinical and Epidemiological Characteristics of Multiple Sclerosis in a Peruvian Cohort: A Retrospective Study Across Three Lima Hospitals. (PubMed, Neurol Int) - Sep 25, 2026 - "The most common initial treatment was interferon-beta (44.7%), while two patients (1.9%) initiated therapy with a highly effective disease-modifying drug (DMD), Ocrelizumab... This study describes clinical characteristics at onset and during follow-up that are largely similar to those reported in international series. However, we found no evidence of improved disease evolution, a finding potentially attributable to the heterogeneity of treatment and management strategies employed across the cohort."
Journal • Retrospective data • CNS Disorders • Movement Disorders • Multiple Sclerosis
|
|
Ana Cruz Cruz; Eduardo Alvarado; Edward Smith; Ivan Dueñas-Pacheco; Julio Perez-Villegas
|